AQST
Aquestive Therapeutics Inc
4.60$
+2.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 07 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 51.5% | 23.9% | 25.5% | 46.1% | 18.0% | 46.0% | 24.1% | 35.7% | 42.1% | 28.5% | 27.7% | 48.7% | 37.4% | 41.4% | 41.7% | 16.3% | 36.1% | 39.0% | 24.8% | 29.1% | 33.1% | 30.4% | 34.3% | 39.5% | 40.3% | 49.7% | 42.5% | 50.0% | 36.9% | 35.4% | 36.4% | 22.5% | 32.8% | 38.1% | 41.9% | 45.6% | 35.2% | 44.8% | 24.0% | 29.1% | 33.0% | |
| 48.5% | 68.4% | 74.5% | 53.9% | 82.0% | 54.0% | 75.9% | 64.3% | 57.9% | 71.5% | 72.3% | 51.3% | 62.6% | 58.6% | 58.3% | 83.7% | 63.9% | 61.0% | 75.2% | 70.9% | 66.9% | 69.6% | 65.7% | 60.5% | 59.7% | 50.3% | 57.5% | 50.0% | 63.1% | 64.6% | 63.6% | 77.5% | 67.2% | 61.9% | 58.1% | 54.4% | 64.8% | 55.2% | 76.0% | 70.9% | 67.0% | |
| 41.2% | 29.8% | 32.5% | 43.4% | 20.9% | 51.4% | 20.9% | 57.4% | 34.2% | 33.8% | 34.0% | 73.2% | 40.8% | 18.6% | 49.7% | 17.7% | 87.9% | 61.9% | 32.9% | 27.8% | 35.6% | 39.7% | 38.9% | 39.2% | 28.2% | 40.0% | 31.9% | 26.2% | 24.6% | 21.9% | 49.2% | 20.7% | 38.9% | 41.4% | 61.5% | 41.0% | 35.4% | 24.6% | 29.1% | 28.7% | 29.4% | |
| 249.1% | 70.0% | 37.3% | 46.9% | 22.7% | 62.0% | 32.3% | 241.6% | 93.1% | 111.2% | 141.6% | 146.0% | 110.4% | 100.3% | 166.7% | 64.1% | 142.9% | 204.4% | 140.1% | 85.6% | 91.3% | 135.2% | 106.1% | 117.5% | 108.7% | 110.6% | 67.0% | 55.6% | 56.8% | 72.3% | 88.7% | 56.5% | 89.5% | 134.9% | 218.7% | 127.0% | 119.1% | 252.2% | 76.0% | 86.0% | 131.2% | |
| 341.7% | 101.6% | 69.8% | 90.3% | 43.6% | 113.5% | 53.3% | 299.0% | 127.2% | 144.9% | 175.7% | 219.2% | 151.2% | 119.0% | 216.4% | 81.9% | 230.8% | 279.9% | 151.9% | 113.4% | 126.9% | 175.0% | 145.0% | 156.7% | 136.9% | 150.6% | 98.8% | 81.8% | 81.4% | 94.2% | 137.9% | 77.2% | 128.5% | 176.3% | 280.2% | 168.0% | 154.4% | 276.7% | 105.1% | 130.4% | 164.6% | |
| -241.7% | -1.6% | 4.8% | -36.4% | 38.4% | -59.5% | 22.7% | -234.7% | -69.4% | -73.4% | -103.4% | -167.9% | -88.6% | -60.3% | -158.1% | 1.8% | -166.8% | -218.9% | -76.6% | -42.5% | -60.0% | -105.3% | -79.4% | -96.2% | -77.2% | -100.3% | -41.4% | -31.8% | -18.3% | -29.6% | -74.3% | 0.3% | -61.2% | -114.4% | -222.1% | -113.6% | -89.6% | -221.6% | -29.1% | -59.5% | -97.5% | |
| 110.1% | 11.9% | 11.1% | 17.5% | 7.3% | 16.2% | 8.2% | 13.8% | 14.6% | 11.3% | 15.2% | 17.4% | 21.4% | 17.1% | 31.6% | 12.7% | 33.6% | 66.1% | 55.3% | 40.6% | 49.6% | 32.4% | 28.4% | 26.9% | 32.2% | 16.0% | 13.4% | 10.8% | 10.1% | 24.5% | 34.8% | 20.9% | 31.0% | 35.6% | 49.1% | 42.7% | 33.4% | 32.8% | 27.2% | 27.8% | 30.2% | |
| -234.4% | -23.1% | -8.9% | -52.9% | 31.1% | -82.3% | 17.5% | -262.0% | -113.3% | -82.9% | -116.5% | -184.0% | -148.3% | -77.0% | -188.6% | -10.8% | -200.4% | -284.9% | -131.9% | -80.6% | -109.5% | -261.3% | -107.7% | -122.9% | -109.4% | -115.6% | 72.5% | -41.6% | -16.7% | -60.7% | -106.4% | -13.7% | -85.0% | -143.8% | -263.0% | -135.4% | -120.6% | -244.8% | -55.8% | -165.5% | -144.6% | |
| 0.0% | 0.0% | 11.1% | 17.5% | 0.0% | 16.2% | 8.3% | 8.1% | 14.6% | 6.7% | -3.8% | 1.4% | 21.4% | -4.0% | 1.2% | 0.1% | 0.1% | -15.4% | 0.0% | 2.4% | 0.0% | 171.7% | 28.4% | 26.7% | 0.0% | 54.3% | -100.9% | 2.1% | -1.1% | 0.8% | 1.4% | – | – | -0.1% | – | – | – | – | – | – | – | |
| -234.4% | -23.1% | -8.9% | -52.9% | 31.1% | -82.3% | 17.5% | -262.0% | -113.3% | -82.9% | -116.5% | -184.0% | -148.3% | -77.0% | -188.6% | -10.8% | -200.4% | -284.9% | -131.9% | -80.6% | -109.5% | -261.3% | -107.7% | -122.9% | -109.4% | -115.6% | 72.5% | -43.7% | -15.7% | -61.4% | -106.4% | -13.7% | -85.0% | -143.7% | -263.0% | -135.4% | -120.6% | -244.8% | -55.8% | -165.5% | -144.6% | |
| – | – | 10.4% | -26.9% | 42.0% | -58.2% | 29.8% | -242.6% | -93.2% | -67.1% | -95.0% | -159.7% | -120.9% | -55.5% | -146.9% | 5.6% | -158.8% | -203.3% | -69.9% | -35.2% | -54.4% | -222.3% | -73.4% | -90.9% | -72.0% | -96.0% | 88.7% | -28.6% | -4.7% | -32.6% | -69.9% | 8.2% | -52.8% | -107.0% | -212.3% | -91.3% | -86.2% | -211.0% | -27.7% | -135.9% | -113.3% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.